COVID-19 Information and Funding Opportunities

Continuing Services

Research Development Services office will continue to actively support the Mason community during the time of reduced campus operations. All staff will be working remotely but continue to provide support to faculty, students and staff in managing the Limited Submission Opportunities and internal application reviews as needed; creating training materials for proposal development; providing proposal management and support for large, complex, multidisciplinary proposals; and offering guidance on seeking funding opportunities through the Sponsored Programs Innovation Network (SPIN). All staff will be working remotely. Please feel free to contact Rebekah Hersch, Assistant Vice President, Research Development (rhersch@gmu.edu) if you have questions. For information about the Limited Submission Opportunities, please contact Sheila Davis (sdavis46@gmu.edu).

COVID-19 Datasets and Analytic Resources

COVID-19 Funding Opportunities

The following table lists funding opportunities relating to the COVID-19 virus. We will continue to update this list as new opportunities become available. If you would like to add opportunities to this list please feel free to contact Sheila Davis at sdavis@gmu.edu.

Program TitleSponsorDeadlineFunding AmountBrief Synopsis
Competitive Grant Program: Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social SciencePfizer Pharmaceuticals27-June-22$125,000; 1 YearPfizer is issuing this Request for Proposals (RFP) to support projects that will focus on a meta-analysis of current behavioral and social science research of COVID-19 vaccine confidence/hesitancy in groups/subgroups who are most at risk due to disparities and social determinants of health.
WH-AST-22-005: Addressing Eating Disorders and the COVID-19 PandemicDepartment of Health and Human Services /Office of the Assistant Secretary for Health15-July-22$500,000; 3 YearsThis notice solicits applications to fund up to three projects focusing on adolescent girls at risk for eating disorders exacerbated by the COVID-19 pandemic. Each project will identify, develop, and implement an evidence-based intervention(s) aimed at detecting and preventing eating disorders.
Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAANational Institute on Alcohol Abuse and Alcoholism5-June-22None postedThis Notice of Special Interest (NOSI) solicits grant applications that advance understanding of critical interactions between alcohol use, SARS-CoV-2, and COVID-19. A central focus is research that can improve public health by informing responses to the evolving COVID-19 pandemic and its consequences.
The RADx-UP CDCC Rapid Research Pilot ProgramRADx-UP26-Aug-22 (LOI), 16-Sept-22 (App); 23-Dec-22 (LOI), 13-Jan-23 (App)$200,000Duke University in partnership with the University of North Carolina, Chapel Hill, is serving as the Coordination and Data Collection Center (CDCC) for the National Institutes of Health (NIH)-supported Rapid Acceleration of Diagnostics- Underserved Populations (RADx-UP) program. The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in communities of underserved and vulnerable populations. The purpose of the overall program is to better understand factors that have led to the disproportionate impact of COVID-19 on these groups, and develop interventions to reduce those disparities.
NOT-HS-22-010: AHRQ Announces Interest in Health Services Research on Health System and Healthcare Professional Responsiveness to COVID-19Agency for Healthcare Research and QualityNone PostedNone postedThis Special Emphasis Notice (SEN) informs the research community that the Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to develop models of care that improve access, quality, and outcomes of care related to COVID-19 and post-acute sequalae from COVID-19 (PASC).
NOT-HL-23-003: Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated CoagulopathyNational Heart, Lung, and Blood Institute (NHLBI)5-Jun-22None PostedThis Notice of Special Interest (NOSI) aims to accelerate a comprehensive understanding of the mechanisms of COVID-19-Associated Coagulopathy (CAC) which are provoked by vascular endothelial cell injury, hyperimmune responses, and hypercoagulability at genomic, molecular, and cellular levels.
Knowledge obtained from such studies may be applied to the future design of early diagnostics and effective treatment for high-risk patients as well as enable CAC research findings to be applied to on-going COVID-19 clinical trials.
PAR-22-112: Urgent Award: COVID=19 Mental Health Research (R01 Clinical Trial Required)National Institutes of Health/National Institute of Mental Health/DHHS25-Aug-22; 23-Dec-22$750,000 per year; 3 Years.This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through rapid acceleration of research to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions to respond to new and worsening mental illness and HIV-related outcomes among those who experience COVID-19 as well as the broader population impacted by the pandemic. All research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting health disparities.
PAR-22-113: Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)National Institutes of Health/National Institute of Mental Health/DHHS25-Aug-22; 23-Dec-22$750,000 per year; 3 Years.This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through 1) understanding mechanisms by which mental illness impacts SARS-CoV-2 morbidity and mortality, 2) exploring how COVID-19 contributes to incident mental illness or HIV-outcomes, 3) identifying modifiable targets uniquely or robustly implicated in the pandemic that are relevant to new and worsening mental illness, and 4) conducting mechanistic trials probing biological or behavioral processes of those targets that may be pursued in future mental health therapeutic development. Research is anticipated to be informed by and directed towards vulnerable populations based on evidence of preexisting and worsened health disparities.
Fast GrantsEmergent Ventures None Posted$500,000 Emergent Ventures invites applications from scientists at academic institutions currently working on a COVID-19 related project and in need of funding. Fast Grants will range from $10,000 to $500,000.
Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 within the Mission of NIAAANational Institute on Alcohol Abuse and Alcoholism/NIH/DHHSNone Posted$100,000 The NOSI invites administrative supplements and competitive revisions to existing grants and cooperative agreements that advance understanding of critical interactions between alcohol, SARS-CoV-2, and COVID-19. A principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic and its consequences.
Emergency Competitive Revision to Existing NIG Awards (Emergency Supplement - Clinical Trial Optional)National Institutes of Health/DHHSNone PostedNone PostedThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI.
Pioneering Ideas: Exploring the Future to Build a Culture of HealthJohnson (Robert Wood) FoundationNone PostedNot AvailableThe Pioneer team seeks to  anticipate the future, and support unconventional approaches and breakthrough ideas that can help lead the way to a future where everyone in the United States can live their healthiest life possible. The Pioneering Ideas: Exploring the Future to Build a Culture of Health call for proposals (CFP) seeks applications from visionary thinkers across the nation who are doing cutting-edge work to advance health equity.
COVID-19 HPC ConsortiumExtreme Science and Engineering Discovery Environment (XSEDE)None PostedNot AvailableThe COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. XSEDE hopes to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world.
COVID-19 Vaccines: Accelerating Vaccine Development and Global Manufacturing Capacity to Stop the PandemicCoalition for Epidemic Preparedness Innovations (CEPI)None PostedNot AvailableThe objective of this Call for Proposals is to support the rapid development of vaccines against COVID-19 with a goal of achieving licensure/emergency authorisation in 12-18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021.
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)National Institutes for Health/DHHSNone PostedNot AvailableThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI.
Covid-19 Scientific ResearchEuropean Synchrotron Radiation FacilityNone PostedNot AvailableThe ESRF is ready to provide access to its facilities for Covid-19 related research projects. This exceptional access will be granted with the aim to contribute to the international scientific effort to overcome the covid-19 pandemic.
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)National Institutes of Health/DHSSNone PostedNot AvailableThe National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.  Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA.
Expedited, Rapid Access Call for COVID-19 ResearchArgonne National LaboratoryNone PostedNot AvailableArgonne National Laboratory
COVID-19 Research SupportBrookhaven National LaboratoryNone PostedNot AvailableThe Center for Biomolecular Structure team is supporting remote macromolecular crystallography experiments at Beamlines 17-ID-1 (AMX) and 17-ID-2 (FMX) for research projects related to COVID-19.
COVID-19 Vaccine Development AwardMMS Holdings Inc.None Posted$1,000,000The sponsor is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the United States and/or other global health authorities.
Notice of Information: Contributing to the Global COVD-19 Crisis response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the CrisisNational Institutes of Health/DHSSNone PostedNot AvailableThe COVID-19 pandemic is a global health crisis that has engaged the attention of researchers who want to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients’ disease progression, response to therapy, care delivery, or survivorship. NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.
Priority Access Call for Work on Combating COVID-19Scherre (Paul) InstituteNone PostedNot AvailableThe Paul Scherrer Institute (PSI) has opened a "PRIORITY COVID-19 Call” for short proposals and quick peer review to enable rapid access to beamtime. Research proposals shall have the potential to effectively contribute to the understanding of the COVID-19 virus and/or to improve the clinical or public health response and patient care.
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)National Institutes of Health (multiple ICs)Varies by ICApplication budgets are not limited but need to reflect the actual needs of the proposed project.The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI.
Only applications submitted in response to an Emergency NOSI published by an IC will be allowed to apply to this FOA.
Dear Colleague Letter--Coronavirus Disease 2019 (COVID-19)Department of EnergyContinuous SubmissionNot SpecifiedThrough its user facilities, computational power, and enabling infrastructure, DOE has unique capabilities that the scientific community may leverage for the COVID-19 response and recovery. DOE does not provide medical and clinical work; instead, the Department's mission complements the efforts of the National Institutes of Health, the Department of Defense, and other Federal partners by helping to understand the scientific phenomena contributing to COVID-19, from the structure of the SARS-CoV-2 virus, which causes the disease, to models that can mimic its spread. DOE supports significant biologically focused facilities and resources, including the Joint Genome Institute (JGI), National Microbiome Data Collaborative (NMDC), Environmental Molecular Science Laboratory (EMSL), and DOE Systems Biology Knowledgebase (KBase). These and other DOE resources may be used for many studies. The Department encourages submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. The Department is acting rapidly to leverage, and when appropriate provide prioritized access to, the full range of DOE user facilities and other facilities available at national laboratories to support the national and international effort to address COVID-19.
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)National Institutes of Health/DHHSVaries by ICApplication budgets are not limited but need to reflect the actual needs of the proposed project.The National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.
Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA. Individual(s) must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award. Individuals are encouraged to work with their organizations to develop applications for support